Digipath, Inc. announced the appointment of two new directors, Dr. Cindy Orser and Bruce Raben. Previously, Dr. Orser was the Chief Science Officer of the company's wholly owned subsidiary, Digipath Labs, Inc. As CSO of Digipath Labs since 2014, Cindy has created a replicable cannabis-testing facility in Las Vegas, NV with validated standard operating procedures to ensure cannabis and cannabis-based products are safe once they reach the dispensary shelves. Dr. Orser draws from over 25 years of innovative experience in both academia and private industry. Dr. Orser is the founder of five biotech companies including Adyfe, Cellphire, Big Sky Biosystems, ASDx Biosystems and iPDx Biosciences. She has consulted for the molecular diagnostic and cannabis industry as well as the federal government. For five years, Dr. Orser served as Corporate Senior Scientist and Head of the Biodefense/Biotechnology Initiative at Arete Associates in Washington, D.C. and was a tenured Professor of Biochemistry and Bacteriology at the University of Idaho. Mr. Raben is the co-founder and President of Hudson Capital Advisors BD, LLC. Mr. Raben has been an investment banker, merchant banker and private investor for over 30 years.